All In MedTech

FDA Clearance Tracker · P160017-S089

MiniMed 670G System, MiniMed 770G System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 19, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 19, 2021

Approved

Time to decision

123 days

Received Dec 17, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P160017-S089
Device name
MiniMed 670G System, MiniMed 770G System
Applicant location
Northridge, CA
Received
Dec 17, 2020
Decided
Apr 19, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P160017

Device type

Device class
Class III

Every decision under product code OZP

FDA's approval statement

As written in FDA's record.

Approval to introduce the MiniMed 770G System to the post-approval study and to provide protocol updates to meet enrollment requirements.

Source documents

Other decisions for Medtronic Minimed, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.